Cancer Registry Software Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Cancer Registry Software Market to 2027 - Global Analysis and Forecasts by Type (Standalone Software, Integrated Software); Deployment Model (On-Premise Models, Cloud-Based Models); Database Type (Commercial Database, Public Databases); Functionality (Cancer Reporting to Meet State and Federal Regulations, Patient Care Management, Medical Research and Clinical Studies, Product Outcome Evaluation); End User (Government Organizations and Third Party Administrators, Hospitals and Medical Practices, Private Players, Pharmaceutical, Biotechnology and Medical Device Companies, Research Centers)

Report Code: TIPRE00003995 | No. of Pages: 150 | Category: Healthcare IT | Status: Upcoming
MARKET INTRODUCTION
Cancer Registry is a computerized database that uses software solutions to organize, collect and store data of the cancer patients and evaluate cancer-specific upshots, circumstances and drug/medical device exposure.

MARKET DYNAMICS
The Cancer Registry Software Market is anticipated to grow in the forecast period owing to driving factors such as rising ubiquity of cancer, favorable government initiatives, rising use of cancer patient registry data for post marketing surveillance and increasing number of accountable care organizations. Nevertheless, privacy and data security related concerns and reluctance to adopt advanced solutions may restrict the growth of the market during the forecast period.

MARKET SCOPE
The "Global Cancer Registry Software Analysis to 2027" is a specialized and in-depth study of the healthcare IT industry with a special focus on the global market trend analysis. The report aims to provide an overview of Cancer Registry software Market with detailed market segmentation by Type, Deployment Model, Database Type, Functionality, End User and Geography. The global Cancer Registry software Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Cancer Registry software Market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global is segmented on the basis of Type, Deployment Model, Database Type, Functionality and End User. Based on Type the market is segmented into Standalone Software and Integrated Software. Based on Deployment Model the market is segmented into On-Premise Models and Cloud-Based Models. Based on Database Type the market is segmented into Commercial Database and Public Databases. Based on Functionality the market is segmented into Cancer Reporting to Meet State and Federal Regulations, Patient Care Management, Medical Research & Clinical Studies and Product Outcome Evaluation. Based on End User the market is segmented into Government Organizations & Third Party Administrators, Hospitals & Medical Practices, Private Players, Pharmaceutical, Biotechnology and Medical Device Companies and Research Centers.


REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Cancer Registry software Market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Cancer Registry software Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Cancer Registry software Market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Cancer Registry software Market in these regions.


MARKET PLAYERS
The reports cover key developments in the Cancer Registry software Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Cancer Registry software Market are anticipated to lucrative growth opportunities in the future with the rising demand for Cancer Registry software Market in the global market. Below mentioned is the list of few companies engaged in the Cancer Registry software Market.

The report also includes the profiles of key Cancer Registry software Market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Onco, Inc
  • C/Net Solutions
  • Elekta AB
  • Rocky Mountain Cancer Data Systems
  • Electronic Registry Systems, Inc
  • Mckesson Corporation
  • Ordinal Data, Inc
  • Conduent, Inc
  • IBM
  • Himagine solutions inc
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cancer Registry Software Market - By Type
1.3.2 Cancer Registry Software Market - By Deployment Model
1.3.3 Cancer Registry Software Market - By Database Type
1.3.4 Cancer Registry Software Market - By Functionality
1.3.5 Cancer Registry Software Market - By End User
1.3.6 Cancer Registry Software Market - By Region
1.3.6.1 By Country

2. KEY TAKEWAYS

3. RESEARCH METHODOLOGY

4. CANCER REGISTRY SOFTWARE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. CANCER REGISTRY SOFTWARE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. CANCER REGISTRY SOFTWARE MARKET - GLOBAL MARKET ANALYSIS
6.1. CANCER REGISTRY SOFTWARE - GLOBAL MARKET OVERVIEW
6.2. CANCER REGISTRY SOFTWARE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. CANCER REGISTRY SOFTWARE MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. STANDALONE SOFTWARE
7.3.1. Overview
7.3.2. Standalone Software Market Forecast and Analysis
7.4. INTEGRATED SOFTWARE
7.4.1. Overview
7.4.2. Integrated Software Market Forecast and Analysis

8. CANCER REGISTRY SOFTWARE MARKET - REVENUE AND FORECASTS TO 2027 - DEPLOYMENT MODEL
8.1. OVERVIEW
8.2. DEPLOYMENT MODEL MARKET FORECASTS AND ANALYSIS
8.3. ON-PREMISE MODELS
8.3.1. Overview
8.3.2. On-Premise Models Market Forecast and Analysis
8.4. CLOUD-BASED MODELS
8.4.1. Overview
8.4.2. Cloud-Based Models Market Forecast and Analysis

9. CANCER REGISTRY SOFTWARE MARKET - REVENUE AND FORECASTS TO 2027 - DATABASE TYPE
9.1. OVERVIEW
9.2. DATABASE TYPE MARKET FORECASTS AND ANALYSIS
9.3. COMMERCIAL DATABASE
9.3.1. Overview
9.3.2. Commercial Database Market Forecast and Analysis
9.4. PUBLIC DATABASES
9.4.1. Overview
9.4.2. Public Databases Market Forecast and Analysis

10. CANCER REGISTRY SOFTWARE MARKET - REVENUE AND FORECASTS TO 2027 - FUNCTIONALITY
10.1. OVERVIEW
10.2. FUNCTIONALITY MARKET FORECASTS AND ANALYSIS
10.3. CANCER REPORTING TO MEET STATE AND FEDERAL REGULATIONS
10.3.1. Overview
10.3.2. Cancer Reporting to Meet State and Federal Regulations Market Forecast and Analysis
10.4. PATIENT CARE MANAGEMENT
10.4.1. Overview
10.4.2. Patient Care Management Market Forecast and Analysis
10.5. MEDICAL RESEARCH AND CLINICAL STUDIES
10.5.1. Overview
10.5.2. Medical Research and Clinical Studies Market Forecast and Analysis
10.6. PRODUCT OUTCOME EVALUATION
10.6.1. Overview
10.6.2. Product Outcome Evaluation Market Forecast and Analysis

11. CANCER REGISTRY SOFTWARE MARKET - REVENUE AND FORECASTS TO 2027 - END USER
11.1. OVERVIEW
11.2. END USER MARKET FORECASTS AND ANALYSIS
11.3. GOVERNMENT ORGANIZATIONS AND THIRD PARTY ADMINISTRATORS
11.3.1. Overview
11.3.2. Government Organizations and Third Party Administrators Market Forecast and Analysis
11.4. HOSPITALS AND MEDICAL PRACTICES
11.4.1. Overview
11.4.2. Hospitals and Medical Practices Market Forecast and Analysis
11.5. PRIVATE PLAYERS
11.5.1. Overview
11.5.2. Private Players Market Forecast and Analysis
11.6. PHARMACEUTICAL
11.6.1. Overview
11.6.2. Pharmaceutical Market Forecast and Analysis
11.7. BIOTECHNOLOGY AND MEDICAL DEVICE COMPANIES
11.7.1. Overview
11.7.2. Biotechnology and Medical Device Companies Market Forecast and Analysis
11.8. RESEARCH CENTERS.
11.8.1. Overview
11.8.2. Research Centers. Market Forecast and Analysis

12. CANCER REGISTRY SOFTWARE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America Cancer Registry Software Market Overview
12.1.2 North America Cancer Registry Software Market Forecasts and Analysis
12.1.3 North America Cancer Registry Software Market Forecasts and Analysis - By Type
12.1.4 North America Cancer Registry Software Market Forecasts and Analysis - By Deployment Model
12.1.5 North America Cancer Registry Software Market Forecasts and Analysis - By Database Type
12.1.6 North America Cancer Registry Software Market Forecasts and Analysis - By Functionality
12.1.7 North America Cancer Registry Software Market Forecasts and Analysis - By End User
12.1.8 North America Cancer Registry Software Market Forecasts and Analysis - By Countries
12.1.8.1 United States Cancer Registry Software Market
12.1.8.1.1 United States Cancer Registry Software Market by Type
12.1.8.1.2 United States Cancer Registry Software Market by Deployment Model
12.1.8.1.3 United States Cancer Registry Software Market by Database Type
12.1.8.1.4 United States Cancer Registry Software Market by Functionality
12.1.8.1.5 United States Cancer Registry Software Market by End User
12.1.8.2 Canada Cancer Registry Software Market
12.1.8.2.1 Canada Cancer Registry Software Market by Type
12.1.8.2.2 Canada Cancer Registry Software Market by Deployment Model
12.1.8.2.3 Canada Cancer Registry Software Market by Database Type
12.1.8.2.4 Canada Cancer Registry Software Market by Functionality
12.1.8.2.5 Canada Cancer Registry Software Market by End User
12.1.8.3 Mexico Cancer Registry Software Market
12.1.8.3.1 Mexico Cancer Registry Software Market by Type
12.1.8.3.2 Mexico Cancer Registry Software Market by Deployment Model
12.1.8.3.3 Mexico Cancer Registry Software Market by Database Type
12.1.8.3.4 Mexico Cancer Registry Software Market by Functionality
12.1.8.3.5 Mexico Cancer Registry Software Market by End User
12.1.8.4 US Cancer Registry Software Market
12.1.8.4.1 US Cancer Registry Software Market by Type
12.1.8.4.2 US Cancer Registry Software Market by Deployment Model
12.1.8.4.3 US Cancer Registry Software Market by Database Type
12.1.8.4.4 US Cancer Registry Software Market by Functionality
12.1.8.4.5 US Cancer Registry Software Market by End User
12.2. EUROPE
12.2.1 Europe Cancer Registry Software Market Overview
12.2.2 Europe Cancer Registry Software Market Forecasts and Analysis
12.2.3 Europe Cancer Registry Software Market Forecasts and Analysis - By Type
12.2.4 Europe Cancer Registry Software Market Forecasts and Analysis - By Deployment Model
12.2.5 Europe Cancer Registry Software Market Forecasts and Analysis - By Database Type
12.2.6 Europe Cancer Registry Software Market Forecasts and Analysis - By Functionality
12.2.7 Europe Cancer Registry Software Market Forecasts and Analysis - By End User
12.2.8 Europe Cancer Registry Software Market Forecasts and Analysis - By Countries
12.2.8.1 Germany Cancer Registry Software Market
12.2.8.1.1 Germany Cancer Registry Software Market by Type
12.2.8.1.2 Germany Cancer Registry Software Market by Deployment Model
12.2.8.1.3 Germany Cancer Registry Software Market by Database Type
12.2.8.1.4 Germany Cancer Registry Software Market by Functionality
12.2.8.1.5 Germany Cancer Registry Software Market by End User
12.2.8.2 France Cancer Registry Software Market
12.2.8.2.1 France Cancer Registry Software Market by Type
12.2.8.2.2 France Cancer Registry Software Market by Deployment Model
12.2.8.2.3 France Cancer Registry Software Market by Database Type
12.2.8.2.4 France Cancer Registry Software Market by Functionality
12.2.8.2.5 France Cancer Registry Software Market by End User
12.2.8.3 Italy Cancer Registry Software Market
12.2.8.3.1 Italy Cancer Registry Software Market by Type
12.2.8.3.2 Italy Cancer Registry Software Market by Deployment Model
12.2.8.3.3 Italy Cancer Registry Software Market by Database Type
12.2.8.3.4 Italy Cancer Registry Software Market by Functionality
12.2.8.3.5 Italy Cancer Registry Software Market by End User
12.2.8.4 Spain Cancer Registry Software Market
12.2.8.4.1 Spain Cancer Registry Software Market by Type
12.2.8.4.2 Spain Cancer Registry Software Market by Deployment Model
12.2.8.4.3 Spain Cancer Registry Software Market by Database Type
12.2.8.4.4 Spain Cancer Registry Software Market by Functionality
12.2.8.4.5 Spain Cancer Registry Software Market by End User
12.2.8.5 United Kingdom Cancer Registry Software Market
12.2.8.5.1 United Kingdom Cancer Registry Software Market by Type
12.2.8.5.2 United Kingdom Cancer Registry Software Market by Deployment Model
12.2.8.5.3 United Kingdom Cancer Registry Software Market by Database Type
12.2.8.5.4 United Kingdom Cancer Registry Software Market by Functionality
12.2.8.5.5 United Kingdom Cancer Registry Software Market by End User
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific Cancer Registry Software Market Overview
12.3.2 Asia-Pacific Cancer Registry Software Market Forecasts and Analysis
12.3.3 Asia-Pacific Cancer Registry Software Market Forecasts and Analysis - By Type
12.3.4 Asia-Pacific Cancer Registry Software Market Forecasts and Analysis - By Deployment Model
12.3.5 Asia-Pacific Cancer Registry Software Market Forecasts and Analysis - By Database Type
12.3.6 Asia-Pacific Cancer Registry Software Market Forecasts and Analysis - By Functionality
12.3.7 Asia-Pacific Cancer Registry Software Market Forecasts and Analysis - By End User
12.3.8 Asia-Pacific Cancer Registry Software Market Forecasts and Analysis - By Countries
12.3.8.1 Australia Cancer Registry Software Market
12.3.8.1.1 Australia Cancer Registry Software Market by Type
12.3.8.1.2 Australia Cancer Registry Software Market by Deployment Model
12.3.8.1.3 Australia Cancer Registry Software Market by Database Type
12.3.8.1.4 Australia Cancer Registry Software Market by Functionality
12.3.8.1.5 Australia Cancer Registry Software Market by End User
12.3.8.2 China Cancer Registry Software Market
12.3.8.2.1 China Cancer Registry Software Market by Type
12.3.8.2.2 China Cancer Registry Software Market by Deployment Model
12.3.8.2.3 China Cancer Registry Software Market by Database Type
12.3.8.2.4 China Cancer Registry Software Market by Functionality
12.3.8.2.5 China Cancer Registry Software Market by End User
12.3.8.3 India Cancer Registry Software Market
12.3.8.3.1 India Cancer Registry Software Market by Type
12.3.8.3.2 India Cancer Registry Software Market by Deployment Model
12.3.8.3.3 India Cancer Registry Software Market by Database Type
12.3.8.3.4 India Cancer Registry Software Market by Functionality
12.3.8.3.5 India Cancer Registry Software Market by End User
12.3.8.4 Japan Cancer Registry Software Market
12.3.8.4.1 Japan Cancer Registry Software Market by Type
12.3.8.4.2 Japan Cancer Registry Software Market by Deployment Model
12.3.8.4.3 Japan Cancer Registry Software Market by Database Type
12.3.8.4.4 Japan Cancer Registry Software Market by Functionality
12.3.8.4.5 Japan Cancer Registry Software Market by End User
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa Cancer Registry Software Market Overview
12.4.2 Middle East and Africa Cancer Registry Software Market Forecasts and Analysis
12.4.3 Middle East and Africa Cancer Registry Software Market Forecasts and Analysis - By Type
12.4.4 Middle East and Africa Cancer Registry Software Market Forecasts and Analysis - By Deployment Model
12.4.5 Middle East and Africa Cancer Registry Software Market Forecasts and Analysis - By Database Type
12.4.6 Middle East and Africa Cancer Registry Software Market Forecasts and Analysis - By Functionality
12.4.7 Middle East and Africa Cancer Registry Software Market Forecasts and Analysis - By End User
12.4.8 Middle East and Africa Cancer Registry Software Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa Cancer Registry Software Market
12.4.8.1.1 South Africa Cancer Registry Software Market by Type
12.4.8.1.2 South Africa Cancer Registry Software Market by Deployment Model
12.4.8.1.3 South Africa Cancer Registry Software Market by Database Type
12.4.8.1.4 South Africa Cancer Registry Software Market by Functionality
12.4.8.1.5 South Africa Cancer Registry Software Market by End User
12.4.8.2 Saudi Arabia Cancer Registry Software Market
12.4.8.2.1 Saudi Arabia Cancer Registry Software Market by Type
12.4.8.2.2 Saudi Arabia Cancer Registry Software Market by Deployment Model
12.4.8.2.3 Saudi Arabia Cancer Registry Software Market by Database Type
12.4.8.2.4 Saudi Arabia Cancer Registry Software Market by Functionality
12.4.8.2.5 Saudi Arabia Cancer Registry Software Market by End User
12.4.8.3 U.A.E Cancer Registry Software Market
12.4.8.3.1 U.A.E Cancer Registry Software Market by Type
12.4.8.3.2 U.A.E Cancer Registry Software Market by Deployment Model
12.4.8.3.3 U.A.E Cancer Registry Software Market by Database Type
12.4.8.3.4 U.A.E Cancer Registry Software Market by Functionality
12.4.8.3.5 U.A.E Cancer Registry Software Market by End User
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America Cancer Registry Software Market Overview
12.5.2 South and Central America Cancer Registry Software Market Forecasts and Analysis
12.5.3 South and Central America Cancer Registry Software Market Forecasts and Analysis - By Type
12.5.4 South and Central America Cancer Registry Software Market Forecasts and Analysis - By Deployment Model
12.5.5 South and Central America Cancer Registry Software Market Forecasts and Analysis - By Database Type
12.5.6 South and Central America Cancer Registry Software Market Forecasts and Analysis - By Functionality
12.5.7 South and Central America Cancer Registry Software Market Forecasts and Analysis - By End User
12.5.8 South and Central America Cancer Registry Software Market Forecasts and Analysis - By Countries
12.5.8.1 Brazil Cancer Registry Software Market
12.5.8.1.1 Brazil Cancer Registry Software Market by Type
12.5.8.1.2 Brazil Cancer Registry Software Market by Deployment Model
12.5.8.1.3 Brazil Cancer Registry Software Market by Database Type
12.5.8.1.4 Brazil Cancer Registry Software Market by Functionality
12.5.8.1.5 Brazil Cancer Registry Software Market by End User
12.5.8.2 Argentina Cancer Registry Software Market
12.5.8.2.1 Argentina Cancer Registry Software Market by Type
12.5.8.2.2 Argentina Cancer Registry Software Market by Deployment Model
12.5.8.2.3 Argentina Cancer Registry Software Market by Database Type
12.5.8.2.4 Argentina Cancer Registry Software Market by Functionality
12.5.8.2.5 Argentina Cancer Registry Software Market by End User

13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

14. CANCER REGISTRY SOFTWARE MARKET, KEY COMPANY PROFILES
14.1. ONCO, INC
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. C/NET SOLUTIONS
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. ELEKTA AB
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. ROCKY MOUNTAIN CANCER DATA SYSTEMS
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. ELECTRONIC REGISTRY SYSTEMS, INC
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. MCKESSON CORPORATION
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. ORDINAL DATA, INC
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. CONDUENT, INC
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. IBM
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. HIMAGINE SOLUTIONS INC
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments

15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies
  1. Onco, Inc
  2. C/Net Solutions
  3. Elekta AB
  4. Rocky Mountain Cancer Data Systems
  5. Electronic Registry Systems, Inc
  6. Mckesson Corporation
  7. Ordinal Data, Inc
  8. Conduent, Inc
  9. IBM
  10. Himagine solutions inc
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book